Lee Neff honors the memory of her son Philip and makes a difference in the lives of others by volunteering at Riley Hospital for Children at Indiana University Health.
Dr. Eric Prystowsky’s dual interests in detective work and medicine merge perfectly in his chosen field of electrophysiology, which has him doing detective work on a regular basis.
Dr. C. William Hanke, a former president of the American Academy of Dermatology, is recognized internationally for his expertise in Mohs surgery, a precise surgical technique used to treat skin cancer.
Dr. Mary Rouse has grown and developed the Charis Center for Eating Disorders, which now treats 12,000 patients a year from Indiana and surrounding states.
Dr. Michael O. Koch has been pursuing the use of high-intensity focused ultrasound, or HIFU, for the treatment of prostate cancer since shortly after he arrived at Indiana University to chair its urology department in 1998.
The GOP-dominated Senate Appropriations Committee endorsed a move Thursday to sharply curtail the governor’s modest request for $10 million a year in additional funding.
Carmel-based Work Here LLC, whose mobile app uses GPS to connect job-seekers and employers, is entering 15 new metro areas after amassing 36,000 users in Indiana.
Restaurant Brands International Inc. has agreed to buy Popeyes Louisiana Kitchen Inc., adding a fried-chicken outfit to its lineup of burgers and doughnuts. The two chains have about 70 restaurants in the Indianapolis area.
In Lilly’s partnership with Harvard Pilgrim Health Care, the not-for-profit insurer gets additional rebates if fewer patients using Lilly's diabetes treatment Trulicity meet blood sugar goals than expected.
Changes in trade policy would reverberate across Indiana, given its status in a new Brookings Institution study as the most export-dependent state in the country.
Manufacturing employment as a share of total employment is down from 25 percent to less than 10 percent. It has fallen under every U.S. president since Truman.
Merck & Co. on Tuesday announced that it will end a study of its once-promising Alzheimer’s disease drug in patients with mild-to-moderate forms of the condition, just three months after Eli Lilly and Co. announced its own setback in a field that’s been littered with failures.
The bill comes on the heels of Carmel’s recent decision to send letters to 28 residents who rent out their homes on Airbnb, stating that they are in violation of city zoning laws.
Two local men who have been working on a potential blockbuster treatment for a rare and debilitating disease are hopeful that a major injection of venture capital will provide the boost needed to move the drug to market—even if it means sweeping changes for their company.
